Home » Topics » Regulatory » Patents

Patents
RSS

Nurix Therapeutics patents CBLB inhibitors

Nov. 4, 2020

Azitra discovers recombinant microorganisms for treating atopic dermatitis

Nov. 3, 2020

Sichuan Kelun-Biotech Biopharmaceutical synthesizes USP7 inhibitors

Nov. 3, 2020

Peloton Therapeutics identifies RBM39 degradation inducers

Nov. 3, 2020

Rottapharm Biotech discloses new DDR2 inhibitors

Nov. 3, 2020

Enanta Pharmaceuticals divulges new antivirals

Nov. 3, 2020

PRIMEGENE BEIJING discovers TYK2 inhibitors

Nov. 2, 2020

New RET inhibitors identified at Zhejiang Hisun Pharmaceutical

Nov. 2, 2020

Jiangsu Hansoh Pharmaceutical Group and collaborators patent dual GIP-R/GLP-1 agonists

Nov. 2, 2020

Sichuan Kelun-Biotech Biopharmaceutical discovers CCR2/CCR5 antagonists

Nov. 2, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...